Zurcher Kantonalbank (Zurich Cantonalbank) Heron Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$30.1 Billion
Q2 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$2.25 - $4.67 $11,304 - $23,462	5,024 Added 51.72%	14,738 $36,000
Q1 2021 May 03, 2021	SELL	$14.49 - $20.72 $29,037 - $41,522	-2,004 Reduced 17.1%	9,714 $157,000
Q2 2020 Jul 28, 2020	BUY	$10.89 - $21.47 $19,841 - $39,118	1,822 Added 18.41%	11,718 $172,000
Q1 2020 May 06, 2020	BUY	$10.23 - $24.56 $45,656 - $109,611	4,463 Added 82.15%	9,896 $116,000
Q4 2019 Jan 21, 2020	BUY	$17.42 - $26.61 $25,119 - $38,371	1,442 Added 36.13%	5,433 $128,000
Q1 2019 Apr 29, 2019	SELL	$23.15 - $28.34 $17,501 - $21,425	-756 Reduced 15.93%	3,991 $98,000
Q4 2018 Jan 25, 2019	BUY	$22.03 - $32.01 $20,465 - $29,737	929 Added 24.33%	4,747 $123,000
Q3 2018 Nov 09, 2018	BUY	$30.0 - $40.85 $25,890 - $35,253	863 Added 29.2%	3,818 $121,000
Q4 2017 Jan 31, 2018	BUY	$14.8 - $18.85 $19,743 - $25,145	1,334 Added 82.29%	2,955 $53,000
Q3 2017 Nov 08, 2017	BUY	$14.65 - $16.85 $23,747 - $27,313	1,621	1,621 $26,000

Others Institutions Holding HRTX

# of Institutions

193

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

Rubric Capital Management LP New York, NY

26.7M
Shares

$51 Million
2.77% of portfolio
Vanguard Group Inc Valley Forge, PA

8.62M
Shares

$16.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$15.9 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

7.6M
Shares

$14.5 Million
0.05% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$13.3 Million
58.47% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account